Stereotactic body radiotherapy for oligometastases
AC Tree, VS Khoo, RA Eeles, M Ahmed… - The lancet …, 2013 - thelancet.com
The management of metastatic solid tumours has historically focused on systemic treatment
given with palliative intent. However, radical surgical treatment of oligometastases is now …
given with palliative intent. However, radical surgical treatment of oligometastases is now …
Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature
P Ost, A Bossi, K Decaestecker, G De Meerleer… - European urology, 2015 - Elsevier
Context The introduction of novel imaging modalities has increased the detection of
oligometastatic prostate cancer (PCa) recurrence, potentially justifying the use of a …
oligometastatic prostate cancer (PCa) recurrence, potentially justifying the use of a …
Progression-free survival following stereotactic body radiotherapy for oligometastatic prostate cancer treatment-naive recurrence: a multi-institutional analysis
The literature on metastasis-directed therapy for oligometastatic prostate cancer (PCa)
recurrence consists of small heterogeneous studies. This study aimed to reduce the …
recurrence consists of small heterogeneous studies. This study aimed to reduce the …
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
K Decaestecker, G De Meerleer, B Lambert, L Delrue… - Radiation …, 2014 - Springer
Purpose To assess the outcome of prostate cancer (PCa) patients diagnosed with
oligometastatic disease at recurrence and treated with stereotactic body radiotherapy …
oligometastatic disease at recurrence and treated with stereotactic body radiotherapy …
OLIGOPELVIS GETUG P07, a multicenter phase II trial of combined high-dose salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses in …
Background Oligorecurrent pelvic nodal relapse in prostatic cancer is a challenge for
regional salvage treatments. Androgen depriving therapies (ADTs) are a mainstay in …
regional salvage treatments. Androgen depriving therapies (ADTs) are a mainstay in …
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
L Triggiani, F Alongi, M Buglione, B Detti… - British journal of …, 2017 - nature.com
Background: The aim of the present study is to evaluate the impact of metastases-directed
stereotactic body radiotherapy in two groups of oligometastatic prostate cancer (PC) …
stereotactic body radiotherapy in two groups of oligometastatic prostate cancer (PC) …
68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer
C Schmidkonz, M Cordes, D Schmidt, T Bäuerle… - European journal of …, 2018 - Springer
Purpose We aimed at evaluating the role of 68 Ga-PSMA-11 PET/CT-derived metabolic
parameters for assessment of whole-body tumor burden and its capability to determine …
parameters for assessment of whole-body tumor burden and its capability to determine …
Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by …
P Rigatti, N Suardi, A Briganti, LF Da Pozzo, M Tutolo… - European urology, 2011 - Elsevier
BACKGROUND: The management of patients with clinical recurrence of prostate cancer
after radical prostatectomy (RP) remains challenging. OBJECTIVE: To determine whether …
after radical prostatectomy (RP) remains challenging. OBJECTIVE: To determine whether …
A prospective head-to-head comparison of 18F-fluciclovine with 68Ga-PSMA-11 in biochemical recurrence of prostate cancer in PET/CT
B Pernthaler, R Kulnik, C Gstettner… - Clinical nuclear …, 2019 - journals.lww.com
Purpose One of the major challenges for all imaging modalities is accurate detection of
prostate cancer (PCa) recurrence. Beyond the established 68 Ga-PSMA, a novel promising …
prostate cancer (PCa) recurrence. Beyond the established 68 Ga-PSMA, a novel promising …
Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases
U Schick, S Jorcano, P Nouet, M Rouzaud… - Acta …, 2013 - Taylor & Francis
Background. Substantial survival may be observed with oligometastatic prostate cancer.
Combining androgen deprivation (AD) and high-dose external beam radiotherapy (RT) to …
Combining androgen deprivation (AD) and high-dose external beam radiotherapy (RT) to …